Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.
GENOMICS: New Mapping Project Splits the Community
Jennifer Couzin
A new type of genomic map, known as the haplotype map, promises to speed the search for elusive genes involved in complex diseases. But to many biologists, it's an untested concept hardly worthy of the $110 million it will consume. Welcome to the haplotype map, a new type of genome map that, depending on where you look, is eliciting exuberance or exasperation.
The editors suggest the following Related Resources on Science sites:
In Science Magazine
REPORTS
Stacey B. Gabriel, Stephen F. Schaffner, Huy Nguyen, Jamie M. Moore, Jessica Roy, Brendan Blumenstiel, John Higgins, Matthew DeFelice, Amy Lochner, Maura Faggart, Shau Neen Liu-Cordero, Charles Rotimi, Adebowale Adeyemo, Richard Cooper, Ryk Ward, Eric S. Lander, Mark J. Daly, and David Altshuler (21 June 2002) Science296 (5576), 2225.
[DOI: 10.1126/science.1069424] |Abstract »|Full Text »|PDF »|Supplemental Data »
High-throughput discovery of rare human nucleotide polymorphisms by Ecotilling.
B. J. Till, T. Zerr, E. Bowers, E. A. Greene, L. Comai, and S. Henikoff (2006)
Nucleic Acids Res.
34, e99
|Abstract »|Full Text »|PDF »
The impact of SNP density on fine-scale patterns of linkage disequilibrium.
X. Ke, S. Hunt, W. Tapper, R. Lawrence, G. Stavrides, J. Ghori, P. Whittaker, A. Collins, A. P. Morris, D. Bentley, et al. (2004)
Hum. Mol. Genet.
13, 577-588
|Abstract »|Full Text »|PDF »
Refashioning Race: DNA and the Politics of Health Care.
A. FAUSTO-STERLING (2004)
differences
15, 1-37
|PDF »
A Population Threshold for Functional Polymorphisms.
G. K.-S. Wong, Z. Yang, D. A. Passey, M. Kibukawa, M. Paddock, C.-R. Liu, L. Bolund, and J. Yu (2003)
Genome Res.
13, 1873-1879
|Abstract »|Full Text »|PDF »
Using Multiple Drug Exposure Levels to Optimize Power in Pharmacogenetic Trials.